Table 4.
Characteristic pathological features
| Main pathology | Histopathological findings | Areas of atrophy and neuronal loss; further characteristics | |
|---|---|---|---|
| MSA | α-synucleinopathy | α-synuclein(+) oligodendrocytic glial cytoplasmic inclusions (GCIs); α-synuclein(+) neuronal cytoplasmic and intranuclear inclusions; myelin loss | Atrophy in putamen, pons, middle cerebellar peduncle, cerebellum; neuronal loss in putamen, substantia nigra, inferior olivary nucleus, Onuf’s nucleus, intermediolateral cell column; demyelination – striato-pallidal fibers, transverse pontine fibers, olivocerebellar fibers, cerebellar white matter |
| PSP | 4R tauopathy | Tau(+) neurofibrillary globose tangles (4R tau); tufted astrocytes with tau(+) inclusions; tau(+) coiled bodies in oligodendrocytes; thread-like structures (diencephalon, brainstem) | Atrophy of midbrain, superior cerebellar peduncle, prefrontal cortex; neuronal loss in subthalamic nucleus, substantia nigra, cerebellar dentate nucleus; loss of pigment in substantia nigra |
| CBD | 4R tauopathy | Astrocytic plaques (4R tau in terminal processes); pleomorphic tau(+) cortical neuronal inclusions, achromatic ballooned neurons; pretangles (tau(+) cytoplasmic inclusions in neurons); coiled bodies (less than in PSP); sparse tau(+) oligodendroglial lesions; dense, widespread thread-like structures in gray and white matter (neuropil threads) | Atrophy of superior frontal, superior parietal and motor cortices, SMA, perisylvian region, corpus callosum; neuronal loss in globus pallidum, substantia nigra, subthalamic nucleus; loss of pigment in substantia nigra |
| FTLD-tau | 3R, 4R or 3R + 4R tauopathies | Tau(+) cytoplasmic inclusions in neurons and glia Pick’s disease: 3R tau(+) neuronal cytoplasmatic inclusions (Pick bodies); ballooned neurons (Pick cells); sparse glial inclusions Argyrophilic grain disease: 4R tau(+) grains, oligodendroglial coiled bodies, ballooned neurons NFT dementia: 3R + 4R tau(+) neuronal inclusions (neurofibrillary tangles) |
Bilateral atrophy with neuronal loss and astrogliosis of frontal and temporal cortices, including medial temporal regions, spreading to more posterior areas (parietal cortex) in disease course |
| FTLD-TDP | TDP-43 proteinopathy | TDP-43(+), ubiquitin(+), p62-sequestosome(+) neuronal cytoplasmic and intranuclear inclusions; oligodendroglial and astrocytic inclusions; superficial cortical laminar spongiosis subtypes A, B, C and D | Cortical atrophy (frontal > temporal and parietal lobes), hippocampus, amygdala, basal ganglia (caudate > putamen > globus pallidus) |
| FTLD-TDP with C9orf72 mutation | TDP-43 proteinopathy | TDP-43(+) inclusions; in addition to TDP-43 pathology: dipeptide repeat protein(+), ubiquitin(+), p62-sequestosome(+) neuronal and glial inclusions (cerebellar granule cells); nuclear RNA foci | Cortical atrophy (frontal > temporal and parietal lobes), motor cortex (some cases), hippocampus, amygdala, basal ganglia (caudate > putamen > globus pallidus); neuronal loss in brainstem, spinal cord motor neurons |
| FTLD-FET | Ubiquitinopathy | FUS(+), ubiquitin(+), p62-sequestosome(+) neuronal cytoplasmic and neuronal intranuclear inclusions | Cortical atrophy (frontal > temporal and parietal lobes), striatal atrophy (severe) |